| LMT |
Report |
Operating EPS |
BEAT |
pred ~$7.40 vs. cons $7.31 |
MEDIUM |
| LMT |
Report |
Net sales |
BEAT |
pred ~$19.55B vs. cons $19.33B |
MEDIUM |
| LMT |
Report |
MFC sales |
BEAT |
pred ~$4.14B vs. cons $4.02B |
MEDIUM |
| LMT |
Guide |
FY2026 sales |
UNCHANGED |
guide $77.5B-$80.0B vs. cons $79.16B |
MEDIUM |
| LMT |
Guide |
FY2026 segment operating profit |
UNCHANGED |
guide $8.425B-$8.675B vs. cons $8.57B |
MEDIUM |
| LMT |
Guide |
FY2026 FCF |
BETTER |
guide $6.5B-$6.8B vs. cons $6.30B |
MEDIUM |
| LMT |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.0% |
— |
LOW |
| LMT |
Return |
5-day cumulative residual |
+2.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest operational beat with a de-rated setup, capped by maintained FY guidance |
LOW |